Left Atrial Appendage Closure Device Market Size Worth USD 8.2 billion by 2031 | CAGR of 21.0%

December 08, 2023 06:53 AM GMT | By EIN Presswire
Follow us on Google News:

Rise in number product approvals for atrial intervention and surge in atrial fibrillation, heart stroke cases, & hypertension-related disease drive the growth

PORTLAND, OREGON, UNITED STATES, December 8, 2023 /EINPresswire.com/ -- Allied Market Research has published a study report with the title Left Atrial Appendage Closure Device Market Size was Valued at USD 1.3 billion in 2021, and is Projected to Garner USD 8.2 billion by 2031, registering a CAGR of 21.0% from 2022 to 2031.

Left atrial appendage closure (LAAC) device is a medical implant used to treat atrial fibrillation (AFib), a heart condition where the upper chambers of the heart beat irregularly and rapidly. The LAAC device is designed to be placed inside the heart to close off the left atrial appendage (LAA), a small sac-like structure located in the heart's left atrium. By blocking the LAA, the LAAC device helps to prevent blood clots from forming and traveling to other parts of the body, such as the brain, where they can cause a stroke. The device is implanted using minimally invasive techniques such as transcatheter implantation.

๐†๐ž๐ญ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐๐ƒ๐… ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐ฐ๐ข๐ญ๐ก ๐†๐ซ๐š๐ฉ๐ก๐ฌ ๐š๐ง๐ ๐…๐ข๐ ๐ฎ๐ซ๐ž๐ฌ ๐‡๐ž๐ซ๐ž: https://www.alliedmarketresearch.com/request-sample/3699

๐–๐ก๐š๐ญ ๐€๐ซ๐ž ๐ญ๐ก๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ƒ๐ซ๐ข๐ฏ๐ž๐ซ๐ฌ ๐Ÿ๐จ๐ซ ๐‹๐ž๐Ÿ๐ญ ๐š๐ญ๐ซ๐ข๐š๐ฅ ๐š๐ฉ๐ฉ๐ž๐ง๐๐š๐ ๐ž ๐œ๐ฅ๐จ๐ฌ๐ฎ๐ซ๐ž (๐‹๐€๐€๐‚) ๐๐ž๐ฏ๐ข๐œ๐ž?

โ€ข Increasing prevalence of atrial fibrillation (AFib) worldwide, leading to a higher risk of stroke and systemic embolism.
โ€ข Growing demand for minimally invasive procedures to reduce hospital stays, lower healthcare costs, and improve patient outcomes.
โ€ข Advancements in technology leading to the development of more effective and safer LAAC devices.
โ€ข Favorable reimbursement policies for LAAC procedures in many countries.
โ€ข Rising awareness about the benefits of LAAC devices among patients, physicians, and healthcare providers.

๐“๐จ๐ฉ ๐Š๐ž๐ฒ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ ๐จ๐Ÿ ๐‹๐ž๐Ÿ๐ญ ๐€๐ญ๐ซ๐ข๐š๐ฅ ๐€๐ฉ๐ฉ๐ž๐ง๐๐š๐ ๐ž ๐‚๐ฅ๐จ๐ฌ๐ฎ๐ซ๐ž ๐ƒ๐ž๐ฏ๐ข๐œ๐ž

โ€ข SentreHEART, Inc.
โ€ข Boston Scientific Corporation
โ€ข AtriCure, Inc.
โ€ข Abbott Laboratories
โ€ข Occlutech
โ€ข Lifetech Scientific Corporation
โ€ข Cardia, Inc.
โ€ข Aegis Medical Group
โ€ข Biosense Webster, Inc.
โ€ข Johnson & Johnson Services, Inc

๐‹๐ž๐Ÿ๐ญ ๐€๐ญ๐ซ๐ข๐š๐ฅ ๐€๐ฉ๐ฉ๐ž๐ง๐๐š๐ ๐ž ๐‚๐ฅ๐จ๐ฌ๐ฎ๐ซ๐ž ๐ƒ๐ž๐ฏ๐ข๐œ๐ž ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ฌ๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง ๐œ๐š๐ง ๐›๐ž ๐๐จ๐ง๐ž ๐›๐š๐ฌ๐ž๐ ๐จ๐ง ๐ฌ๐ž๐ฏ๐ž๐ซ๐š๐ฅ ๐Ÿ๐š๐œ๐ญ๐จ๐ซ๐ฌ, ๐ข๐ง๐œ๐ฅ๐ฎ๐๐ข๐ง๐ :

Based on product, the endocardial LAA devices segment contributed to the highest market share in 2021, accounting for around 90% of the global left atrial appendage closure device market, and is projected to maintain its lead position during the forecast period. Moreover, this segment is estimated to manifest the largest CAGR of 21.2% from 2022 to 2031. This is due to lower complications in patients, shorter hospital stays, and safer and more effective in managing stroke and reducing bleeding than other products. The report also analyzes the epicardial LAA devices segment.

Based on end use, the hospitals segment accounted for the largest market share in 2021, holding around three-fourths of the global left atrial appendage closure device market, and is estimated to continue its highest contribution throughout the forecast period. In addition, this segment is projected to register the fastest CAGR of 21.4% from 2022 to 2031. This is due to preference for left atrial appendage (LAA) procedures and increase in hospital acceptance of LAA closure devices with availability of advanced medical technologies and skilled professionals. The research also analyzes the segments including ambulatory surgery centers and others.

Based on region, North America held the largest market share in 2021, accounting for nearly half of the global left atrial appendage closure device market, and is projected to maintain its dominance in terms of revenue during the forecast period. This is due to widespread acceptance of advanced left atrial appendage closure devices, rise in incidence of atrial fibrillation, and well-developed healthcare infrastructure. However, Asia-Pacific is projected to grow at the largest CAGR of 22.2% from 2022 to 2031, owing to high preference and acceptance of advanced technologies in closure devices in medical facilities in the region.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/3699

Our Market Research Solution Provides You Answer to Below Mentioned Question:

โ€ข Which are the driving factors responsible for the growth of market?
โ€ข Which are the roadblock factors of this market?
โ€ข What are the new opportunities, by which market will grow in coming years?
โ€ข What are the trends of this market?
โ€ข Which are main factors responsible for new product launch?
โ€ข How big is the global & regional market in terms of revenue, sales and production?
โ€ข How far will the market grow in forecast period in terms of revenue, sales and production?
โ€ข Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
โ€ข How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
โ€ข Which region has more opportunities?

By Region Outlook

โ€ข North America
(U.S., Canada, Mexico)
โ€ข Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
โ€ข Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
โ€ข LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

Contact Details:

David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
[email protected]

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โ€œMarket Research Reportsโ€ and โ€œBusiness Intelligence Solutions.โ€ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

David Correa
Allied Analytics LLP
+1 800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.



Top ASX Listed Companies

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK